EVGN vs EXOZ

Evogene Ltd. vs eXoZymes Inc. — Valuation Comparison 2026

EVGN

Biotechnology
Evogene Ltd.
Quality
1.9
out of 10
Value Trap
6
SAFE
Price
$0.72
Last close
Models
9/13
Active
VS

EXOZ

Biotechnology
eXoZymes Inc.
Quality
4.5
out of 10
Value Trap
Price
$9.72
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType EVGN Fair ValueEVGN Upside EXOZ Fair ValueEXOZ Upside
Bayesian DCF Intrinsic $0.19 -73.5% $2.58 -73.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.57 -19.4% $0.29 -97.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $4.11 +475.3%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVGN vs EXOZ — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVGN vs EXOZ — Which Stock Is More Undervalued?

EXOZ scores higher with a 4.5/10 quality rating vs EVGN's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evogene Ltd. (EVGN) and eXoZymes Inc. (EXOZ) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVGN currently trades at $0.72 with a QOC of 1.9/10, while EXOZ trades at $9.72 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).